Free Trial

Cochlear Limited (OTCMKTS:CHEOY) Sees Significant Growth in Short Interest

Cochlear logo with Medical background

Cochlear Limited (OTCMKTS:CHEOY - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 4,100 shares, an increase of 4,000.0% from the March 15th total of 100 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 33,100 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group initiated coverage on Cochlear in a research report on Thursday, January 16th. They set a "neutral" rating for the company.

Read Our Latest Analysis on Cochlear

Cochlear Stock Performance

Cochlear stock traded up $0.85 during trading hours on Friday, reaching $83.15. 16,943 shares of the company's stock were exchanged, compared to its average volume of 18,079. The firm's 50 day simple moving average is $83.48 and its 200 day simple moving average is $91.68. Cochlear has a twelve month low of $74.76 and a twelve month high of $115.85.

Cochlear Increases Dividend

The business also recently disclosed a dividend, which will be paid on Tuesday, April 29th. Stockholders of record on Friday, March 21st will be issued a dividend of $0.6165 per share. The ex-dividend date is Friday, March 21st. This is a positive change from Cochlear's previous dividend of $0.14.

Cochlear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Further Reading

Should You Invest $1,000 in Cochlear Right Now?

Before you consider Cochlear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cochlear wasn't on the list.

While Cochlear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines